Porter T R, Eckberg D L, Fritsch J M, Rea R F, Beightol L A, Schmedtje J F, Mohanty P K
Department of Medicine, Veterans Administration Medical Center, Richmond Virginia.
J Clin Invest. 1990 May;85(5):1362-71. doi: 10.1172/JCI114580.
We conducted this study in an effort to characterize and understand vagal abnormalities in heart failure patients whose sympathetic activity is known. We measured sympathetic (peroneal nerve muscle sympathetic recordings and antecubital vein plasma norepinephrine levels) and vagal (R-R intervals and their standard deviations) activities in eight heart failure patients and eight age-matched healthy volunteers, before and after parasympathomimetic and parasympatholytic intravenous doses of atropine sulfate. At rest, sympathetic and parasympathetic outflows were related reciprocally: heart failure patients had high sympathetic and low parasympathetic outflows, and healthy subjects had low sympathetic and high parasympathetic outflows. Low dose atropine, which is known to increase the activity of central vagal-cardiac motoneurons, significantly increased R-R intervals in healthy subjects, but did not alter R-R intervals in heart failure patients. Thus, our data document reciprocal supranormal sympathetic and subnormal parasympathetic outflows in heart failure patients and suggest that these abnormalities result in part from abnormalities within the central nervous system.
我们开展这项研究,旨在描述并了解已知交感神经活动的心力衰竭患者的迷走神经异常情况。我们测量了8名心力衰竭患者和8名年龄匹配的健康志愿者在静脉注射拟副交感神经药和副交感神经阻滞药硫酸阿托品前后的交感神经(腓总神经肌肉交感神经记录和肘前静脉血浆去甲肾上腺素水平)和迷走神经活动(R-R间期及其标准差)。静息状态下,交感神经和副交感神经输出呈反比关系:心力衰竭患者交感神经输出高,副交感神经输出低,而健康受试者交感神经输出低,副交感神经输出高。已知低剂量阿托品可增加中枢迷走神经-心脏运动神经元的活性,它能显著增加健康受试者的R-R间期,但不会改变心力衰竭患者的R-R间期。因此,我们的数据证明了心力衰竭患者交感神经输出超常而副交感神经输出低于正常水平,并且提示这些异常部分是由中枢神经系统内的异常导致的。